ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,826Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 252

$617K Total Retail Price of All Prescriptions

Rank: 68 out of 252

484 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 11,920 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
AMLODIPINE BESYLATE 519 492 1 4
LEVOTHYROXINE SODIUM 461 437 2 1
PRAVASTATIN SODIUM 438 392 3 12
HYDROCODONE-ACETAMINOPHEN 384 368 S3 4 5
OMEPRAZOLE 382 345 5 6
LOSARTAN POTASSIUM 347 328 6 24
CARVEDILOL 345 335 7 22
HYDROCHLOROTHIAZIDE 303 298 8 13
FUROSEMIDE 265 241 9 7
GABAPENTIN 248 230 10 11
POTASSIUM CHLORIDE 244 217 11 8
METOPROLOL SUCCINATE 227 219 12 19
LISINOPRIL 210 195 13 3
SPIRONOLACTONE 202 202 14 53
SIMVASTATIN 202 189 14 2
METFORMIN HCL 196 172 16 9
WARFARIN SODIUM 196 196 16 14
CITALOPRAM HBR 189 185 18 15
METOPROLOL TARTRATE 182 164 19 10
QUINAPRIL HCL 178 168 20 120
DONEPEZIL HCL 169 169 21 28
ENALAPRIL MALEATE 144 138 22 72
ALENDRONATE SODIUM 143 143 23 32
ATORVASTATIN CALCIUM 125 117 24 16
TRAMADOL HCL 112 91 25 17
ATENOLOL 108 98 26 18
FINASTERIDE 103 102 27 115
DIGOXIN 96 96 28 44
RAMIPRIL 95 95 29 71
TRAMADOL HCL-ACETAMINOPHEN 94 94 30 133
CLOPIDOGREL 93 87 31 29
BUMETANIDE 91 91 32 139
ZOLPIDEM TARTRATE 91 68 32 21
PREDNISONE 89 88 34 42
ALLOPURINOL 89 89 34 30
RANITIDINE HCL 79 75 36 48
NEXIUM 78 66 37 23
NAMENDA 78 78 37 41
DILTIAZEM 24HR CD 73 72 39 104
TRIAMTERENE-HCTZ 73 73 39 33
FENOFIBRATE 72 67 41 64
INSULIN SYRINGE 71 63 42 93
GLIPIZIDE ER 71 67 42 90
DOXAZOSIN MESYLATE 70 70 44 73
TRAZODONE HCL 66 49 45 31
SYNTHROID 64 64 46 47
CRESTOR 63 56 47 34
TAMSULOSIN HCL 63 58 47 26
LANTUS 63 47 47 55
PANTOPRAZOLE SODIUM 59 49 50 62
PLAVIX 59 53 50 43
AMIODARONE HCL 58 58 52 142
VENLAFAXINE HCL ER 57 57 53 105
MIRTAZAPINE 56 55 54 58
FLUTICASONE PROPIONATE 56 54 54 36
GLIPIZIDE 52 40 56 52
SERTRALINE HCL 51 44 57 27
FLUOXETINE HCL 51 45 57 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.